Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
770.63
545.92
618.12
663.88
979.76
800.27
307.41
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
770.63
545.92
618.12
663.88
979.76
800.27
307.41
Raw Material Cost
593.09
451.07
445.08
460.96
665.10
536.44
207.88
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
85.27
76.11
86.90
82.54
84.61
0.00
26.31
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.76
0.91
1.14
1.99
1.84
0.75
0.09
Selling and Distribution Expenses
67.75
54.50
51.73
39.95
31.46
22.05
17.49
Other Expenses
-6.36
-5.95
-6.71
-6.02
-5.08
2.64
-1.57
Total Expenditure (Excl Depreciation)
684.28
523.10
517.76
525.27
732.22
585.62
236.10
Operating Profit (PBDIT) excl Other Income
86.4
22.799999999999997
100.39999999999999
138.6
247.5
214.7
71.3
Other Income
17.38
34.65
41.72
31.34
9.60
-2.12
12.95
Operating Profit (PBDIT)
147.22
97.39
177.38
200.47
283.72
225.17
94.80
Interest
1.76
0.91
1.14
1.99
1.84
0.75
0.09
Exceptional Items
-4.01
-12.45
-1.45
-1.90
0.78
-0.57
-1.76
Gross Profit (PBDT)
177.53
94.85
173.04
202.92
314.66
263.83
99.53
Depreciation
54.59
47.70
38.98
34.41
30.81
16.79
14.37
Profit Before Tax
86.85
36.34
135.82
162.16
251.85
207.06
78.57
Tax
9.18
5.97
20.46
21.20
31.81
27.43
10.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
77.27
19.46
115.20
140.97
220.05
179.63
68.12
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
77.27
19.46
115.20
140.97
220.05
179.63
68.12
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.13
-0.29
-0.66
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
77.40
19.17
114.54
140.97
220.05
179.63
68.12
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,881.87
1,827.03
1,858.65
1,779.13
1,693.43
441.55
264.20
Earnings per share (EPS)
0.69
0.17
1.01
1.24
1.94
1.58
0.6
Diluted Earnings per share
0.69
0.17
1.01
1.24
1.94
1.58
0.6
Operating Profit Margin (Excl OI)
9.76%
2.76%
15.64%
20.29%
24.83%
26.3%
21.95%
Gross Profit Margin
18.35%
15.39%
28.28%
29.61%
28.85%
27.97%
30.23%
PAT Margin
10.03%
3.57%
18.64%
21.23%
22.46%
22.45%
22.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 41.16% vs -11.68% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 303.13% vs -83.23% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 107.02% vs -53.80% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 100.00% vs -18.18% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Tongling Jieya Biologic Technology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
770.63
0
770.63
Other Operating Income
0.00
0.00
0.00
Total Operating income
770.63
0
770.63
Raw Material Cost
593.09
0
593.09
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
85.27
0
85.27
Power Cost
0
0
0.00
Manufacturing Expenses
1.76
0
1.76
Selling and Distribution Expenses
67.75
0
67.75
Other Expenses
-6.36
0.00
-6.36
Total Expenditure (Excl Depreciation)
684.28
0
684.28
Operating Profit (PBDIT) excl Other Income
86.35
0.00
86.35
Other Income
17.38
0
17.38
Operating Profit (PBDIT)
147.22
0
147.22
Interest
1.76
0
1.76
Exceptional Items
-4.01
0
-4.01
Gross Profit (PBDT)
177.53
0
177.53
Depreciation
54.59
0
54.59
Profit Before Tax
86.85
0
86.85
Tax
9.18
0
9.18
Provisions and contingencies
0
0
0.00
Profit After Tax
77.27
0
77.27
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
77.27
0
77.27
Share in Profit of Associates
0
0
0.00
Minority Interest
0.13
0
0.13
Other related items
0.00
0.00
0.00
Consolidated Net Profit
77.40
0
77.40
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,881.87
0
1,881.87
Earnings per share (EPS)
0.69
0
0.69
Diluted Earnings per share
0.69
0
0.69
Operating Profit Margin (Excl OI)
9.76%
0%
0.00
9.76%
Gross Profit Margin
18.35%
0%
0.00
18.35%
PAT Margin
10.03%
0%
0.00
10.03%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 77.06 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 41.16% vs -11.68% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 7.74 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 303.13% vs -83.23% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.98 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 107.02% vs -53.80% in Dec 2024
Annual - Interest
Interest 0.18 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 100.00% vs -18.18% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.76%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






